Finance

Lists
Why is MDCX up 2.66%?
Dive Deeper
MDCX:NASDAQ
Medicus Pharma Ltd
$1.93
+2.66%
(+0.050) 1D
$1.70
-11.92% (-0.23)
Pre-market
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDCX...
Open
$1.86
High
$1.98
Low
$1.78
Mkt. cap
3.57M
Avg. vol.
2.02M
Volume
155.00
52-wk high
$127.50
52-wk low
$1.78
EPS
-$122.54
Shares outstanding
1.89M
No. of employees
16
Open
$1.86
High
$1.98
Low
$1.78
Mkt. cap
3.57M
Avg. vol.
2.02M
Volume
155.00
52-wk high
$127.50
52-wk low
$1.78
EPS
-$122.54
Shares outstanding
1.89M
No. of employees
16
News stories
From web sources and news partners
About Medicus Pharma Ltd
CEO-
Employees16
Founded2008
HeadquartersConshohocken, Pennsylvania, United States
SectorBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to MDCX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MDCX in the last 3 months.
Highest
Current $1.93
$450.00 (+23,216.06%)
Average
$171.67 (+8,794.82%)
Lowest
$15.00 (+677.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$15.00
+677.2%
10/16/2026
Matthew Venezia
Alliance Global Partners
Buy
Maintained
$50.00
+2,490.7%
09/14/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$1.00
-48.2%
09/14/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$450.00
+23,216.1%
09/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.68M
2.59M
2.70M
4.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.02M
5.20M
5.89M
6.57M
Operating expense
6.71M
7.79M
8.60M
11.48M
Total operating expenses
6.71M
7.79M
8.60M
11.48M
Operating income
-6.71M
-7.79M
-8.60M
-11.48M
Other non operating income
-4.95M
-6.88M
-
-
EBT including unusual items
-20.94M
-15.07M
-9.04M
-11.68M
EBT excluding unusual items
-11.65M
-14.95M
-8.92M
-11.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.94M
-15.07M
-9.04M
-11.62M
Net profit margin
-
-
-
-
Earnings per share
-54.66
-22.21
-15.09
-10.50
Interest and investment income
11.57K
-
56.56K
-
Interest expense
-
-272.82K
-374.71K
-205.64K
Net interest expenses
11.57K
-272.82K
-318.15K
-205.64K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps